Clinical trial
Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
NCT00032487 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00032487 |
|---|---|
| Title | Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) |
| Official title | CSP #465 - Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) |
| Acronym | VADT |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Collaborators | National Eye Institute (NEI) NIH SmithKline Beecham Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Insulin, Glimepiride, Rosiglitazone, Metformin |
| Enrollment | 1,791 |
| Start date | Dec 1, 2000 |
| Primary completion | May 30, 2008 |
| Completion | May 30, 2008 |
| First posted | Mar 22, 2002 |
| Last update posted | Mar 30, 2017 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: